Specifically, BMAL1 has been shown to suppress cancer cell invasion by antagonizing the oncogene B-cell lymphoma w (Bcl-w), thus suppressing matrix metalloproteinase-2 (MMP-2) accumulation and blocking the PI3K-AKT-MMP2 signaling pathway [64]. Here, MMP2 is linked to cancer.